Montefiore Medical Center
Clinical trials sponsored by Montefiore Medical Center, explained in plain language.
-
New lung cancer trial combines immunotherapy and targeted radiation
Disease control Not yet recruitingThis phase 2 trial tests two different immunotherapy drug combinations (durvalumab with monalizumab or oleclumab) followed by personalized radiation for people with advanced non-small cell lung cancer that has a high PD-L1 score. The goal is to see which combination works better …
Phase: PHASE2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
Could Cannabis-Based drugs help opioid patients stay in treatment?
Symptom relief Not yet recruitingThis study tests whether adding two FDA-approved cannabinoids (dronabinol and epidiolex) to standard buprenorphine treatment helps people with opioid use disorder stay in treatment and reduce opioid use. About 40 adults who recently started buprenorphine and still have withdrawal…
Phase: PHASE3 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 11, 2026 12:10 UTC
-
Antibiotics may not be needed for mild diverticulitis, U.S. study challenges standard care.
Symptom relief Not yet recruitingThis study tests whether people with mild diverticulitis can safely recover at home using only pain relievers instead of antibiotics. Researchers will compare hospital admission rates between two groups: one receiving antibiotics plus pain meds, and another receiving pain meds al…
Phase: PHASE4 • Sponsor: Montefiore Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC
-
Can a smartphone app improve cancer care? new study aims to find out
Knowledge-focused Not yet recruitingThis study is testing a mobile app called RestoreMe that gives personalized nutrition and activity advice to cancer patients. Researchers will enroll 150 people who are about to start, are currently receiving, or have finished cancer treatment. The goal is to see if patients find…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:09 UTC